Back to companies
Monte Rosa Therapeutics, Inc.
GLUEUSNASDAQPharmaceuticals & HealthcareMonte Rosa Therapeutics, Inc.
Revenue
$123.7mn
YoY +63.5%
Operating income
-$54.2mn
FY2025
Employees
—
Founded
—
Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API